News
Search EMA's news announcements
Review will assess risk of leukoencephalopathy, a condition affecting the brain
PRAC starts safety review of levamisole, a medicine used to treat parasitic worm infections
Illegal medicines marketed as GLP-1 receptor agonists for weight loss and diabetes pose serious risk to health
Key partnership leverages EMA’s scientific expertise and WHO’s mandate to improve access to safe and effective medicines worldwide
The European Medicines Agency's (EMA) office is closed from 18:00 on 14 August 2025 to 08:30 on 18 August 2025
13 new medicines recommended for approval; another 8 medicines recommended for extension of their therapeutic indications
The new propellant in Trixeo Aerosphere and Riltrava Aerosphere has lower global warming potential
Injectable lenacapavir, administered twice yearly, is highly effective at preventing HIV
Vaccine to be used only when there is a significant chikungunya risk and after careful consideration of the benefits and risks
Aqneursa significantly improves neurological signs, symptoms and functioning